Medicare Drug Price Negotiation Program and Medicare Prescription Drug Benefit Program
Health and Human Services Department · Proposed Rule
Summary
This proposed rule would codify the Medicare Drug Price Negotiation Program ("Negotiation Program") and would establish certain new policies for the Negotiation Program and the Medicare Prescription Drug Benefit Program as required by the Inflation Reduction Act of 2022. This proposed rule would also propose a modification to the fixed combination drug policy.
Affected frameworks & controls
No framework controls are mapped to this item yet.
Key dates
- Status
- Proposed
- Category
- HealthcareHIPAA
- Published
- Jun 16, 2026
- Effective
- —
- Comments close
- Aug 17, 2026
View source document Download PDF